AUG 13, 2026 · JOURNAL ARTICLE
Gut microbiota and the gut–liver axis in MASLD: mechanisms, immune regulation and therapeutic opportunities
Frontiers in Pharmacology
A narrative review synthesizing mechanistic understanding of gut-liver axis dysregulation in MASLD, offering a framework for understanding disease pathways and therapeutic targets rather than reporting original evidence.
Reported
MASLD prevalencemore than one-third of adults